Note 13 - Segment Information

12 Months Ended

Jun. 30, 2020

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

1

3

.

Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company's operating segments.

The Company has divided its operations into

two

reportable segments; Contract Manufacturing and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the fiscal years ended

June 30, 2020

and

2019

were

$8,473

and

$6,807,

respectively.

Financial information relating to the fiscal years ended

June 30, 2020

and

2019

operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross				Capital		Total
		Customers		Customers		Total		Profit		Depreciation		Expenditures		Assets
Contract Manufacturing	2020	$	42,944	$	8,382	$	51,326	$	6,427	$	310	$	221	$	19,581
	2019		41,817		6,625		48,442		5,780		286		413		17,580
Other Nutraceutical Businesses	2020		1,352		91		1,443		300		2		9		3,363
	2019		1,353		182		1,535		442		2		1		2,210
Total Company	2020		44,296		8,473		52,769		6,727		312		230		22,944
	2019		43,170		6,807		49,977		6,222		288		414		19,790